1.
Bladder cancer
by Kaufman, Donald S, Prof, Dr
The Lancet (British edition), 2009, Vol.374 (9685), p.239-249
2.
Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges
by Mondul, Alison M
Epidemiologic reviews, 2017, Vol.39 (1), p.28-48
3.
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study
by Swerdlow, AJ
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (5), p.1661-1672
4.
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
by Abdollah, Firas
Cancer epidemiology, 2013, Vol.37 (3), p.219-225
5.
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials
by Choudhury, Ananya
The lancet oncology, 2021, Vol.22 (2), p.246-255
6.
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
by Neumann, A
Diabetologia, 2012, Vol.55 (7), p.1953-1962
7.
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
by Levin, D
Diabetologia, 2015, Vol.58 (3), p.493-504
8.
Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014
by Groeben, Christer
Annals of surgical oncology, 2018, Vol.25 (12), p.3502-3509
9.
Water disinfection by-products and bladder cancer: is there a European specificity? A pooled and meta-analysis of European case–control studies
by Costet, N
Occupational and Environmental Medicine, 2011, Vol.68 (5), p.379-385
10.
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
by Schmitz-Dräger, Bernd J
Urologia internationalis, 2015, Vol.94 (1), p.1-24
11.
Evaluation of the carcinogenicity of inorganic arsenic
by Cohen, Samuel M
Critical reviews in toxicology, 2013, Vol.43 (9), p.711-752
12.
Diabetes mellitus and risk of bladder cancer : a meta-analysis
by LARSSON, S. C
Diabetologia, 2006, Vol.49 (12), p.2819-2823
13.
Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: A systematic review and network meta-analysis
by Zhao, Yue, M.D., Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2015, Vol.32 (5), p.515-523
14.
Relationship of Zolpidem and Cancer Risk: A Taiwanese Population-Based Cohort Study
by Kao, Chia-Hung, MD
Mayo Clinic proceedings, 2012, Vol.87 (5), p.430-436
15.
Intake of fruit and vegetables and risk of bladder cancer: a dose–response meta-analysis of observational studies
by Yao, Baodong
Cancer causes & control, 2014, Vol.25 (12), p.1645-1658
16.
Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients
by Ogihara, Koichiro
Annals of surgical oncology, 2015, Vol.23 (5), p.1752-1759
17.
Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle–Control Genes
by Wu, Xifeng
American journal of human genetics, 2006, Vol.78 (3), p.464-479
18.
Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
by Tseng, C.-H
Diabetologia, 2011, Vol.54 (8), p.2009-2015
19.
Point and Interval Estimates of Partial Population Attributable Risks in Cohort Studies: Examples and Software
by Spiegelman, D
Cancer causes & control, 2007, Vol.18 (5), p.571-579
20.
Comparison of variable selection methods for high-dimensional survival data with competing events
by Gilhodes, Julia
Computers in biology and medicine, 2017, Vol.91, p.159-167
